Navigation Links

Biology Technology

Biotech Procurement Company Moves to Office 365 with iomart

7/2/2015
GLASGOW, Scotland , July 2, 2015 Amici Procurement Migrates to the Cloud   Bio-tech procurement company Amici Procurement has chosen Microsoft Cloud Solution Provider iomart (AIM: IOM) to help it move to Office 365.      (Logo: http://photos.prnewswire.com/prnh/20121126/579634) Amici Procurement provides small to medium-sized companies i... [Comments]

Luzi Smart Lamp Recently Launched Indiegogo Campaign

7/2/2015
PALO ALTO, Calif. (PRWEB) July 02, 2015 Sleepless nights will become obsolete as Luzi , a sophisticated smart lamp designed to improve an individual’s quality of sleep, launched its Indiegogo campaign on June 23. Sound sleepers and the sleep deprived both will love Luzi for its design and fu... [Comments]

In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing

7/2/2015
Memphis, TN (PRWEB) July 02, 2015 In’Tech Medical SAS ( http://www.intech-medical.com ), a leader in the development and manufacturing of surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, Inc ., thus becoming a global leader in orthopedic contract-manufa... [Comments]

Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics

7/1/2015
Costa Mesa, CA (PRWEB) July 01, 2015 It is now possible to separate two common disorders: post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) using single photon emission computed tomography (SPECT) according to researchers from Amen Clinics, UCLA, Thomas Jefferson Univer... [Comments]

AgBiome and Genective collaborate to create novel insect-resistant crops

7/1/2015
RESEARCH TRIANGLE PARK, N.C. and PARIS , July 1, 2015  Leading agricultural research firm AgBiome, and Genective, key developer of biotech crops, today announce a strategic partnership to accelerate the discovery of new generations of insect control traits. "Growers need new traits for insect control to counter the realities of advancing insect resistance. We are ple... [Comments]

Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options

7/1/2015
BURLINGTON, Mass. , July 1, 2015   Decision Resources Group finds that the three most frequently cited advantages of Otezla are its oral administration, alternative mechanism of action, and favorable safety profile, as reported by surveyed rheumatologists. Otezla was the first oral therapy specifically approved and launched for the treatment of active psoriatic arthritis... [Comments]

NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research

7/1/2015
(PRWEB) July 01, 2015 The next-generation sequencing (NGS) clinical market is poised for huge growth as it prepares to enter several key market segments, including the molecular diagnostics industry. BCC Research reveals in its new report that the market drivers of this vibrant industry inclu... [Comments]

Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product

7/1/2015
AURORA, Colo. and BANGALORE, India , July 1, 2015  Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer care, today announced the appointment of Scott A. Storrer as chief executive officer. In his expanded role as now president and CEO, he will be responsible for all strategy, business expansion an... [Comments]

Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001

7/1/2015
PALO ALTO, Calif. , July 1, 2015   Neuraltus Pharmaceuticals, Inc. , a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller , M.D., Director of the Forbes Norris MDA/ALS Research Center at Sutter Health's C... [Comments]

Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting

7/1/2015
HAMILTON, Bermuda , July 1, 2015  Axovant Sciences Ltd. (NYSE:  AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced that the company will host an investor briefing on July 22 at 5:45 p.m. EDT following its presentation of RVT-101 clinical data at the Alzheimer's Association International Conference 2015 (AAIC... [Comments]

Isagenix Earns Nine American Business Awards

7/1/2015
CHANDLER, Ariz. , July 1, 2015 Isagenix International, a leading global health and wellness company, announced it has earned three Gold, three Silver, and three Bronze Stevie® Awards at the 2015 Annual American Business Awards gala held in Chicago this month.The American Business Awards are recognized as the premier business awards program in the U.S. "Winning is... [Comments]

Medicine Technology

E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care

7/2/2015
SEOUL , South Korea, July 2, 2015 ALPINION MEDICAL SYSTEMS Co., Ltd., announced today the launch of a new E-CUBE Series ultrasound system. Developed to enhance user experience and patient care in a range of clinical areas, the E-CUBE 15 EX produces superb image quality. With advanced imaging technologies, this system delivers outstanding clinical performance in women's he... [Comments]

BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State

7/2/2015
BOTHELL, Wash. , July 2, 2015   BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers ("BioLife" or the "Company"), today announced that Seattle... [Comments]

Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry

7/2/2015
DUBLIN , June 25, 2015 Research and Markets( http://www.researchandmarkets.com/research/9q4d5d/veterinary_ ) has announced the addition of the "Veterinary / Animal Vaccines Market by Product, Diseases & Technology - Global Forecast to 2020" report to their offering. The global animal vaccines market is poised to reach $7,197.9 Million by 2020 from $5,507.3 Million i... [Comments]

BGI Receives Accreditation from the College of American Pathologists (CAP)

7/2/2015
SHENZHEN, China   , July 2, 2015 BGI announced today that its high-throughput DNA sequencing laboratory in Hong Kong has been accredited by the American College of Pathologists (CAP). The BGI Hong Kong facility is the first clinical next-generation-sequencing laboratory to receive the CAP certification in China , meeting the highest standard in clinical labor... [Comments]

Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding

7/2/2015
ATLANTA , July 2, 2015 Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that U.S. District Judge Joseph Goodwin in the Southern District of West Virginia (VA) consolidated 26 transvaginal mesh cases against Ethicon for a single trial to take place on November 2 nd . The cases for the 26 women include claims from the women plaintiffs that they were i... [Comments]

Wilson Therapeutics Appoints Hans Schikan to its Board of Directors

7/2/2015
STOCKHOLM , July 2, 2015   Wilson Therapeutics AB , a privately-held biopharmaceutical company, today announced the appointment of Hans Schikan to its board of directors. The appointment was approved by the shareholders during the Annual General Meeting on June 30. "We are delighted to welcome Hans to Wilson's board of directors," said Jonas Hansson , CEO of Wilson Ther... [Comments]

ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries

7/2/2015
LONDON , July 2, 2015 Agreement reinforces ViiV Healthcare commitment to improving access to HIV treatments   ViiV Healthcare and Desano Pharmaceuticals (Desano) today announced a strategic manufacturing agreement to enable production in China of dolutegravir. The agreement will offer an additional source of the dolutegravir active pharmaceutical ingredien... [Comments]

Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards

7/1/2015
SCHAUMBURG, Ill. , July 1, 2015 The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients. Biosimilars are medicines that... [Comments]

Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8

7/1/2015
DUBLIN , July 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the company will be webcasting its corporate presentation at the Cantor Fitzgerald Healthcare Conference in New York , NY.  Russell Cox , executive vice president and chief operating officer, will provide an overview of the company and a business and financial update on Wednesday... [Comments]

ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference

7/1/2015
EDISON, N.J. , July 1, 2015 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it will present at the Cantor Fitzgerald Inaugural Healthcare Conference taking place in New York, NY on July 8, 2015 at Le Parker Meridien Hotel. James Sapirstei... [Comments]

Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode

7/1/2015
CENTENNIAL, Colo. , July 1, 2015   Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the US Food and Drug Administration (FDA) approval of the Cochlear™ Nucleus® Profile™ Implant with Slim Straight Electrode (CI522). Built on over 30 years of experience and developed in close collaboration with the world's le... [Comments]

(Date:6/30/2015)... BOSTON , June 30, 2015  Juniper ... company focused on developing therapeutics that address unmet ... CFO George Elston will present at ... , Wednesday, July 8, 2015Time: , 4:45 PM ... NYWebcast (live & archive): , www.juniperpharma.com, under  ...
(Date:6/30/2015)... ... June 30, 2015 , ... With its latest polyacrylonitrile ... to achieve faster flow rates in comparison to nylon or polyethersulfone (PES). ... to allow easy liquid flow while trapping particulates as small as 0.2 micron ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Matrix Marketing ... that it has hired Gem Swartz to head up its account management department as ... director. Both Gem and Amanda bring senior account management and delivery expertise to the ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - RepliCel Life ... stage regenerative medicine company focused on the development ... participant in its Phase 1/2 clinical trial of ... unilateral Achilles tendinosis, has been enrolled and their ... ultrasound-guided injections. RCT-01 is comprised of non-bulbar dermal ...
Breaking Biology Technology:Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2Matrix Marketing Group Expands Client Services Team 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4
... Technologies, Inc. announced this week that it has finalized ... in Avegno for exclusive distribution rights of the AcceleDent™ ... AcceleDent™ System is currently being sold outside the USA ... The lightweight appliance, used to speed up the rate of orthodontic ...
... New York, November 21, 2011 New Report ... to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures ...   Published by  GBI Research . ... to 2017 - Glaucoma and Cataract Surgery Devices, Minimally ...
... 21, 2011 The report " ... Myeloid Leukemia) Pipeline Assessment & Global Market Forecast (2010 ... major market drivers, restraints, and opportunities in North America, ... tables and in-depth TOC on Leukemia Therapeutics Market (Acute/Chronic ...
Cached Biology Technology:OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy 2OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy 3ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 2ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 3ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 4MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020 2MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020 3
(Date:7/1/2015)... , July 1, 2015  AVACEN, Inc. announced today the ... patent covering the medical technology platform supporting its unique Dry ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... methods patent no. 9,066,781 - Methods And Apparatus For Therapeutic ... AVACEN and specific methods of use, referred to by the ...
(Date:7/1/2015)... , July 1, 2015 Rock Creek ... company focused on chronic inflammatory disease and neurologic disorders, ... principle study with anatabine citrate, the Company,s lead compound. ... dose of anatabine citrate can significantly inhibit the activation ... The Company is developing this compound in a Phase ...
(Date:7/1/2015)... 2015 Egalet Corporation (Nasdaq: EGLT ... focused on developing, manufacturing and marketing innovative pain ... president and chief executive officer, is scheduled to ... provide an update on Egalet,s marketed product ... approved product OXAYDO ™ (oxycodone HCI, USP) ...
Breaking Medicine Technology:AVACEN Medical Patent Issued 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3
... 4 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... the Securities and Exchange Commission (SEC) that, if declared effective by ... time, up to $75 million of its common stock, ... in one or more offerings.  As of the date of this ...
... Decision Marks Delay in Potential First Treatment for Deadly Disease ... ... for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is ... of Pirfenidone, which will delay potential approval of the first drug in the treatment ...
Cached Medicine Technology:Alexza Pharmaceuticals Files Shelf Registration Statement 2Alexza Pharmaceuticals Files Shelf Registration Statement 3Alexza Pharmaceuticals Files Shelf Registration Statement 4Coalition for Pulmonary Fibrosis Responds to News of Further Review of Pirfenidone By FDA 2Coalition for Pulmonary Fibrosis Responds to News of Further Review of Pirfenidone By FDA 3Coalition for Pulmonary Fibrosis Responds to News of Further Review of Pirfenidone By FDA 4